問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2025-10-18

楊哲瑞
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

13Cases

2025-09-10 - 2028-06-13

Phase I

Not yet recruiting
A Phase Ib/III Randomized, Multicenter, Global Study of Volrustomig Plus Casdatifan or Volrustomig Monotherapy Versus Nivolumab Plus Ipilimumab as First-line Treatment for Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
  • Condition/Disease

    Advanced Clear Cell Renal Cell Carcinoma

  • Test Drug

    N/A N/A

Participate Sites
4Sites

Recruiting4Sites

2025-12-01 - 2033-05-05

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Recruiting5Sites

2025-06-30 - 2032-05-01

Phase II

Not yet recruiting
A Phase 2, Open-label, Multi-cohort Study to Assess the Efficacy and Safety of ASP5541 in Participants with Advanced Prostate Cancer
  • Condition/Disease

    Advanced Prostate Cancer

  • Test Drug

    ASP5541

Participate Sites
6Sites

Recruiting6Sites

1 2